Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Cramer

Showing results (81-90 of 233) with videos related to

Pageof 24
Sort By:
Fertility Research and Practice|March 13, 2021
Self-reported infertility diagnoses and treatment history approximately 20 years after fertility treatment initiationAlesia M Jung, Stacey A Missmer, Daniel W Cramer, et al.
Gynecologic Oncology|January 28, 2014
Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancerKristina A Williams, S Intidhar Labidi-Galy, Kathryn L Terry, et al.
Cancer Letters|December 30, 2006
Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidenceBin Ye, Margarita Aponte, Yan Dai, et al.
Frontiers in Oncology|May 9, 2022
A Translational Model to Improve Early Detection of Epithelial Ovarian CancersAllison Gockley, Konrad Pagacz, Stephen Fiascone, et al.
International Journal of Molecular Epidemiology and Genetics|October 11, 2012
Genetic variation in telomere maintenance genes in relation to ovarian cancer survivalHolly R Harris, Immaculata De Vivo, Linda J Titus, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|June 25, 2020
Peripheral Blood Leukocyte Telomere Length and EndometriosisNaoko Sasamoto, Jennifer Yland, Allison F Vitonis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 5, 2008
Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancerMargaret A Gates, Shelley S Tworoger, Kathryn L Terry, et al.
Frontiers in Oncology|November 5, 2014
Evidence of differential effects of vitamin d receptor variants on epithelial ovarian cancer risk by predicted vitamin d statusJennifer Prescott, Kimberly A Bertrand, Brett M Reid, et al.
Cancer Research|July 18, 2008
Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancerMargarita Aponte, Wei Jiang, Montaha Lakkis, et al.
International Journal of Cancer|February 26, 2021
Intrauterine device use and risk of ovarian cancer: Results from the New England Case-Control study and Nurses' Health StudiesJiaxi Yang, Naoko Sasamoto, Ana Babic, et al.
Pageof 24

Showing results (81-90 of 233) with videos related to

Sort By:
Pageof 24
Fertility Research and Practice|March 13, 2021
Self-reported infertility diagnoses and treatment history approximately 20 years after fertility treatment initiationAlesia M Jung, Stacey A Missmer, Daniel W Cramer, et al.
Gynecologic Oncology|January 28, 2014
Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancerKristina A Williams, S Intidhar Labidi-Galy, Kathryn L Terry, et al.
Cancer Letters|December 30, 2006
Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidenceBin Ye, Margarita Aponte, Yan Dai, et al.
Frontiers in Oncology|May 9, 2022
A Translational Model to Improve Early Detection of Epithelial Ovarian CancersAllison Gockley, Konrad Pagacz, Stephen Fiascone, et al.
International Journal of Molecular Epidemiology and Genetics|October 11, 2012
Genetic variation in telomere maintenance genes in relation to ovarian cancer survivalHolly R Harris, Immaculata De Vivo, Linda J Titus, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|June 25, 2020
Peripheral Blood Leukocyte Telomere Length and EndometriosisNaoko Sasamoto, Jennifer Yland, Allison F Vitonis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 5, 2008
Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancerMargaret A Gates, Shelley S Tworoger, Kathryn L Terry, et al.
Frontiers in Oncology|November 5, 2014
Evidence of differential effects of vitamin d receptor variants on epithelial ovarian cancer risk by predicted vitamin d statusJennifer Prescott, Kimberly A Bertrand, Brett M Reid, et al.
Cancer Research|July 18, 2008
Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancerMargarita Aponte, Wei Jiang, Montaha Lakkis, et al.
International Journal of Cancer|February 26, 2021
Intrauterine device use and risk of ovarian cancer: Results from the New England Case-Control study and Nurses' Health StudiesJiaxi Yang, Naoko Sasamoto, Ana Babic, et al.
Pageof 24